Emily Workman - Publications

Neuroscience University of Texas at Austin, Austin, Texas, U.S.A. 
depression, mTOR

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Wolfe SA, Workman ER, Heaney CF, Niere F, Namjoshi S, Cacheaux LP, Farris SP, Drew MR, Zemelman BV, Harris RA, Raab-Graham KF. FMRP regulates an ethanol-dependent shift in GABABR function and expression with rapid antidepressant properties. Nature Communications. 7: 12867. PMID 27666021 DOI: 10.1038/ncomms12867  1
2016 Raab-Graham KF, Workman ER, Namjoshi S, Niere F. Pushing the threshold: how NMDAR antagonists induce homeostasis through protein synthesis to remedy depression. Brain Research. PMID 27125595 DOI: 10.1016/j.brainres.2016.04.020  1
2015 Sosanya NM, Cacheaux LP, Workman ER, Niere F, Perrone-Bizzozero NI, Raab-Graham KF. Mammalian Target of Rapamycin (mTOR) Tagging Promotes Dendritic Branch Variability through the Capture of Ca2+/Calmodulin-dependent Protein Kinase II α (CaMKIIα) mRNAs by the RNA-binding Protein HuD. The Journal of Biological Chemistry. 290: 16357-71. PMID 25944900 DOI: 10.1074/jbc.M114.599399  0.76
2015 Workman ER, Haddick PC, Bush K, Dilly GA, Niere F, Zemelman BV, Raab-Graham KF. Rapid antidepressants stimulate the decoupling of GABA(B) receptors from GIRK/Kir3 channels through increased protein stability of 14-3-3η. Molecular Psychiatry. 20: 298-310. PMID 25560757 DOI: 10.1038/mp.2014.165  0.76
2014 Most D, Workman E, Harris RA. Synaptic adaptations by alcohol and drugs of abuse: changes in microRNA expression and mRNA regulation. Frontiers in Molecular Neuroscience. 7: 85. PMID 25565954 DOI: 10.3389/fnmol.2014.00085  0.76
2013 Workman ER, Niere F, Raab-Graham KF. mTORC1-dependent protein synthesis underlying rapid antidepressant effect requires GABABR signaling. Neuropharmacology. 73: 192-203. PMID 23752093 DOI: 10.1016/j.neuropharm.2013.05.037  1
Show low-probability matches.